Skip to main content

CORRECTION article

Front. Immunol., 07 March 2018
Sec. Inflammation
Volume 9 - 2018 | https://doi.org/10.3389/fimmu.2018.00357

Corrigendum: 1,25-Dihydroxyvitamin D Inhibits LPS-Induced High-Mobility Group Box 1 (HMGB1) Secretion via Targeting the NF-E2-Related Factor 2–Hemeoxygenase-1–HMGB1 Pathway in Macrophages

This article is a correction to:

  1. 1,25-Dihydroxyvitamin D Inhibits LPS-Induced High-Mobility Group Box 1 (HMGB1) Secretion via Targeting the NF-E2-Related Factor 2–Hemeoxygenase-1–HMGB1 Pathway in Macrophages

    1. Read original article
\r\nZebing Rao,Zebing Rao1,2Na Zhang,Na Zhang1,2Ning XuNing Xu3Ying Pan,Ying Pan1,2Mengjun Xiao,Mengjun Xiao1,2Junxian Wu,Junxian Wu1,2Hong ZhouHong Zhou1Shuo Yang,Shuo Yang1,2Yunzi Chen,,*\r\nYunzi Chen1,2,4*
  • 1Department of Immunology, Nanjing Medical University, Nanjing, China
  • 2Key Laboratory of Antibody Techniques of Ministry of Health, Nanjing Medical University, Nanjing, China
  • 3Department of Pathology, Nanjing Medical University, Nanjing, China
  • 4Medical Centre for Digestive Diseases, Second Affiliated Hospital of Nanjing Medical University, Nanjing, China

A corrigendum on

1,25-Dihydroxyvitamin D Inhibits LPS-Induced High-Mobility Group Box 1 (HMGB1) Secretion via Targeting the NF-E2-Related Factor 2–Hemeoxygenase-1–HMGB1 Pathway in Macrophages
by Rao Z, Zhang N, Xu N, Pan Y, Xiao M, Wu J, et al. Front Immunol (2017) 8:1308. doi: 10.3389/fimmu.2017.01308

In the original article “1,25-Dihydroxyvitamin D Inhibits LPS-Induced HMGB1 Secretion via Targeting the Nrf2-HO-1-HMGB1 Pathway in Macrophages”, we neglected to include the funder, National Natural Science Foundation of China grant (81570499) to Shuo Yang. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: sepsis, vitamin D, inflammation, high-mobility group box 1 protein, damage-associated molecular patterns

Citation: Rao Z, Zhang N, Xu N, Pan Y, Xiao M, Wu J, Zhou H, Yang S and Chen Y (2018) Corrigendum: 1,25-Dihydroxyvitamin D Inhibits LPS-Induced High-Mobility Group Box 1 (HMGB1) Secretion via Targeting the NF-E2-Related Factor 2–Hemeoxygenase-1–HMGB1 Pathway in Macrophages. Front. Immunol. 9:357. doi: 10.3389/fimmu.2018.00357

Received: 28 December 2017; Accepted: 08 February 2018;
Published: 07 March 2018

Edited and Reviewed by: Kottarappat N. Dileepan, Kansas University of Medical Center Research Institute, United States

Copyright: © 2018 Rao, Zhang, Xu, Pan, Xiao, Wu, Zhou, Yang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yunzi Chen, chenyunzi@njmu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.